Skip to main content
Premium Trial:

Request an Annual Quote

Cole-Parmer Acquires Quality Control Standards Manufacturer ZeptoMetrix

NEW YORK — Private equity firm GTCR said on Tuesday that its Cole-Parmer business has acquired ZeptoMetrix, a maker of quality control standards and verification panels used in infectious disease molecular diagnostic testing.

Financial and other terms of the deal were not disclosed.

Buffalo, New York-based ZeptoMetrix's products are used by clinical testing labs to verify that molecular diagnostics are accurately detecting the presence of specific genetic material within a patient sample, according to GTCR. In mid-2020, ZeptoMetrix released quality controls for COVID-19 testing. 

Vernon Hills, Illinois-based Cole-Parmer, which was acquired by GTCR from Thermo Fisher Scientific in 2014, manufactures a range of life science products for applications that include fluidics, environmental sampling and analysis, and sample preparation. GTCR said the acquisition will expand Cole-Parmer's portfolio of quality controls and reference standards.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.